{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T14:16:01Z","timestamp":1790691361810,"version":"4.1.0"},"reference-count":20,"publisher":"Oxford University Press (OUP)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,6,1]]},"DOI":"10.1093\/jac\/dkm088","type":"journal-article","created":{"date-parts":[[2007,4,14]],"date-time":"2007-04-14T00:13:26Z","timestamp":1176509606000},"page":"1148-1154","source":"Crossref","is-referenced-by-count":40,"title":["Modified guidelines impact on antibiotic use and costs: duration of treatment for pneumonia in a neurosurgical ICU is reduced"],"prefix":"10.1093","volume":"59","author":[{"given":"Elisabeth","family":"Meyer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juergen","family":"Buttler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Egid","family":"Strehl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Schroeren-Boersch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Gastmeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henning","family":"Ruden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef","family":"Zentner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franz D.","family":"Daschner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Schwab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2007,4,13]]},"reference":[{"key":"key\n\t\t\t\t20171012174406_DKM088C1","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1001\/jama.1996.03530270074035","article-title":"Strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in hospitals. A challenge to hospital leadership","volume":"275","author":"Goldmann","year":"1996","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20171012174406_DKM088C2","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1093\/clinids\/24.3.471","article-title":"Programmatic role of the infectious diseases physician in controlling antimicrobial costs in the hospital","volume":"24","author":"John","year":"1997","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171012174406_DKM088C3","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1093\/jac\/dkg460","article-title":"Room for improvement: a systematic review of the quality of evaluations of interventions to improve hospital antibiotic prescribing","volume":"52","author":"Ramsay","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20171012174406_DKM088C4","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1001\/jama.290.19.2588","article-title":"Comparison of 8 versus 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial","volume":"290","author":"Chastre","year":"2003","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20171012174406_DKM088C5","first-page":"1","volume-title":"Medical Microbiology\u2014Methods for the Determination of Susceptibility of Pathogens (Except Mycobacteria) to Antimicrobial Agents. Part 4: Evaluation Classes of the Minimum Inhibitory Concentration","author":"DIN 58940\u20134","year":"1998"},{"key":"key\n\t\t\t\t20171012174406_DKM088C6","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1067\/mic.2003.66","article-title":"Five years working with the German nosocomial infection surveillance system (Krankenhaus Infektions Surveillance System)","volume":"31","author":"Gastmeier","year":"2003","journal-title":"Am J Infect Control"},{"key":"key\n\t\t\t\t20171012174406_DKM088C7","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1093\/jac\/dkg459","article-title":"Outcomes of an intervention to improve hospital antibiotic prescribing: interrupted time series with segmented regression analysis","volume":"52","author":"Ansari","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20171012174406_DKM088C8","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1046\/j.1365-2710.2002.00430.x","article-title":"Segmented regression analysis of interrupted time series studies in medication use research","volume":"27","author":"Wagner","year":"2002","journal-title":"J Clin Pharm Ther"},{"key":"key\n\t\t\t\t20171012174406_DKM088C9","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1198-743X.2004.00887.x","article-title":"European recommendations for antimicrobial resistance surveillance","volume":"10","author":"Cornaglia","year":"2004","journal-title":"Clin Microbiol Infect"},{"key":"key\n\t\t\t\t20171012174406_DKM088C10","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1097\/01.CCM.0000171849.04952.79","article-title":"Strategies to prevent antimicrobial resistance in the intensive care unit","volume":"33","author":"Kollef","year":"2005","journal-title":"Crit Care Med"},{"key":"key\n\t\t\t\t20171012174406_DKM088C11","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1093\/jac\/39.4.527","article-title":"Indications for antibiotic use in ICU patients: a one-year prospective surveillance","volume":"39","author":"Bergmans","year":"1997","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20171012174406_DKM088C12","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1164\/ajrccm.153.5.8630626","article-title":"Hospital-acquired pneumonia in adults: diagnosis, assessment of severity, initial antimicrobial therapy, and preventive strategies. A consensus statement, American Thoracic Society, November 1995","volume":"153","author":"Anon","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"key\n\t\t\t\t20171012174406_DKM088C13","doi-asserted-by":"crossref","first-page":"621","DOI":"10.7326\/0003-4819-132-8-200004180-00004","article-title":"Invasive and noninvasive strategies for management of suspected ventilator-associated pneumonia. A randomized trial","volume":"132","author":"Fagon","year":"2000","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t20171012174406_DKM088C14","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1164\/ajrccm.162.2.9909095","article-title":"Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. A proposed solution for indiscriminate antibiotic prescription","volume":"162","author":"Singh","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"key\n\t\t\t\t20171012174406_DKM088C15","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1128\/AAC.46.9.2920-2925.2002","article-title":"Consumption of imipenem correlates with \u03b2-lactam resistance in Pseudomonas aeruginosa.","volume":"46","author":"Lepper","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171012174406_DKM088C16","first-page":"218","article-title":"The impact of carbapenemases on antimicrobial development and therapy","volume":"3","author":"Livermore","year":"2002","journal-title":"Curr Opin Investig Drugs"},{"key":"key\n\t\t\t\t20171012174406_DKM088C17","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1086\/338782","article-title":"Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare?","volume":"34","author":"Livermore","year":"2002","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171012174406_DKM088C18","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.jhin.2004.12.027","article-title":"Temporal changes in bacterial resistance in German intensive care units, 2001\u20132003: data from the SARI (surveillance of antimicrobial use and antimicrobial resistance in intensive care units) project","volume":"60","author":"Meyer","year":"2005","journal-title":"J Hosp Infect"},{"key":"key\n\t\t\t\t20171012174406_DKM088C19","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1007\/s00134-004-2266-9","article-title":"Surveillance of antimicrobial use and antimicrobial resistance in intensive care units (SARI): 1. Antimicrobial use in German intensive care units","volume":"30","author":"Meyer","year":"2004","journal-title":"Intensive Care Med"},{"key":"key\n\t\t\t\t20171012174406_DKM088C20","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1093\/jac\/dkh163","article-title":"Reduction in broad-spectrum antimicrobial use associated with no improvement in hospital antibiogram","volume":"53","author":"Cook","year":"2004","journal-title":"J Antimicrob Chemother"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/59\/6\/1148\/2105626\/dkm088.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,10,12]],"date-time":"2017-10-12T22:49:42Z","timestamp":1507848582000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/jac\/article\/59\/6\/1148\/713351\/Modified-guidelines-impact-on-antibiotic-use-and"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4,13]]},"references-count":20,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2007,4,13]]},"published-print":{"date-parts":[[2007,6,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkm088","relation":{},"ISSN":["1460-2091","0305-7453"],"issn-type":[{"value":"1460-2091","type":"electronic"},{"value":"0305-7453","type":"print"}],"subject":[],"published-other":{"date-parts":[[2007,6]]},"published":{"date-parts":[[2007,4,13]]}}}